Corvus Pharmaceuticals, Inc. (CRVS) market cap

Market cap today
$857.87M

Corvus Pharmaceuticals, Inc. (CRVS) has a market cap of $857.87M. At the end of fiscal 2025 (December 31, 2025) its market cap was $614.02M. That is 88.2% higher than the $326.27M of fiscal 2024. Today's figure is 39.7% above the fiscal 2025 year-end. Figures as of 18 Nov 2026, 12:19 UTC, from the company's filings with the SEC and Yahoo Finance.

Key facts

Market cap today
$857.87M
Market cap, fiscal 2025
$614.02M
Change on fiscal 2024
+88.2%
Growth, 5 years
+42.4% a year
Highest on record
$614.02Mfiscal 2025
Lowest on record
$39.57Mfiscal 2022
Fiscal years on record
72019–2025

Figures as of . Older fiscal years come from the company's filings with the SEC, recent ones from Yahoo Finance. Amounts are in USD. Figures, not advice.

Corvus Pharmaceuticals, Inc. market cap, in more detail

Over the five fiscal years to 2025 the market cap grew at a compound 42.4% a year. Across the 7 fiscal year-ends on record (2019–2025), the highest was $614.02M in fiscal 2025 and the lowest $39.57M in fiscal 2022.

History · 7 fiscal years

Market cap at each fiscal year-end

The last point is today's figure; the others are fiscal year-ends.

Corvus Pharmaceuticals, Inc. market cap, year by year

Corvus Pharmaceuticals, Inc. (CRVS) market cap by fiscal year
Fiscal yearMarket capChangeYear endedShare price at year-endDiluted shares
Today$857.87M—$10.17—
2025$614.02M 88.2% up$7.7079.74M
2024$326.27M 286.0% up$5.3560.99M
2023$84.52M 113.6% up$1.7648.03M
2022$39.57M 60.8% down$0.8546.55M
2021$100.87M 3.9% down$2.4141.85M
2020$104.94M 34.3% down$3.5629.48M
2019$159.66M—$5.4429.35M
2018——$3.67—
2017——$10.36—
2016——$14.30—

Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.

Method

How it is calculated

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote.

How to read it

It is what the stock market says the whole company is worth — a measure of size, not of whether the shares are cheap or dear.

More on CRVS

Corvus Pharmaceuticals, Inc., figure by figure

Corvus Pharmaceuticals, Inc. (CRVS) overview: price, valuation and scorecard

Corvus Pharmaceuticals, Inc. market cap: questions and answers

What is Corvus Pharmaceuticals, Inc.'s market cap?

Corvus Pharmaceuticals, Inc. (CRVS) has a market cap of $857.87M. At the end of fiscal 2025 (December 31, 2025) its market cap was $614.02M. That is 88.2% higher than the $326.27M of fiscal 2024.

What is the growth rate of Corvus Pharmaceuticals, Inc.'s market cap?

Over the five fiscal years to 2025 the market cap grew at a compound 42.4% a year.

What are the highest and lowest market cap figures on record for Corvus Pharmaceuticals, Inc.?

Across the 7 fiscal year-ends on record (2019–2025), the highest was $614.02M in fiscal 2025 and the lowest $39.57M in fiscal 2022.

How is Corvus Pharmaceuticals, Inc.'s market cap calculated?

Market cap is the share price multiplied by the number of shares: for past years this page multiplies the diluted share count in each annual report by the closing price for the month that fiscal year ended in, and today's figure comes from the live quote. For Corvus Pharmaceuticals, Inc. it is on record here for 7 fiscal years, 2019 to 2025.

Share prices are Yahoo Finance's monthly closes: a fiscal year-end is paired with the close of the month it falls in, and today's quote may be delayed. Fiscal years are named for the calendar year they end in.

Cite this page

Funkfolio, “Corvus Pharmaceuticals, Inc. (CRVS) market cap”, data as of 18 November 2026. https://funkfolio.com/stock/CRVS/market-cap

Underlying data: the company's filings with the SEC and Yahoo Finance.